CANNAPHARMARX INC (CPMD) Financial Statements (2024 and earlier)

Company Profile

Business Address SUITE 3600
CALGARY, AB T2P 5C5
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,31727,767334,9691,547682,059 
Cash and cash equivalents2,31727,767334,9691,547682,059 
Receivables 23,2511,77155128,361  
Inventory, net of allowances, customer advances and progress billings      
Inventory      
Prepaid expense 68,539 132,031592,473134,689 
Deposits current assets    1,308,830  
Other current assets 5,906     
Other undisclosed current assets1   (217,941) 
Total current assets:100,01429,538467,5511,931,211598,807 
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 5,127,622   
Operating lease, right-of-use asset    
Property, plant and equipment107,7806,0321,568,7511,563,2601,563,260 
Intangible assets, net (including goodwill)    6,370,3336,065,014 
Goodwill    6,370,3336,065,014 
Other undisclosed noncurrent assets78,76078,7606,711,2896,152,6101,871,000 
Total noncurrent assets:5,314,16284,7928,280,04014,086,2039,499,274 
TOTAL ASSETS:5,414,176114,3308,747,59116,017,41410,098,081 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7,224,8723,323,6642,544,3251,120,4841,500,705604,542
Interest and dividends payable194,40796,47727,63068,052 
Accounts payable6,882,9473,129,2572,447,848902,854766,203 
Accrued liabilities151,925     
Other undisclosed accounts payable and accrued liabilities190,000  190,000666,450604,542
Debt8,856,9188,999,3369,726,3071,090,7942,210,975 
Derivative instruments and hedges, liabilities1,008,868507,4943,676,649   
Estimated litigation liability     190,000
Due to related parties 19,757655,171582,09628,758169,758
Other undisclosed current liabilities74,496190,000946,7381,158,9592,222,000 
Total current liabilities:17,165,15413,040,25117,549,1903,952,3335,962,438964,300
Noncurrent Liabilities
Long-term debt and lease obligation    7,210,8834,421,942 
Long-term debt, excluding current maturities    7,210,8834,421,942 
Other undisclosed noncurrent liabilities5,593,478     
Total noncurrent liabilities:5,593,478  7,210,8834,421,942 
Total liabilities:22,758,63213,040,25117,549,19011,163,21610,384,380964,300
Equity
Equity, attributable to parent, including:(17,344,455)(12,925,920)(8,801,599)4,854,198(286,299)(964,300)
Preferred stock     60,000 
Common stock27,41212,5514,6993,6491,8941,796
Treasury stock, value (13)(13)(13)(13)  
Additional paid in capital74,523,64273,055,57968,336,24961,619,41536,642,27632,930,067
Accumulated other comprehensive income (loss)240,427(371,909)(345,714)137,696  
Accumulated deficit(94,695,339)(86,164,319)(77,331,820)(57,441,549)(36,990,469)(33,896,163)
Other undisclosed equity, attributable to parent2,559,416542,191535,000535,000  
Other undisclosed equity (1)(1)    
Total equity:(17,344,456)(12,925,921)(8,801,599)4,854,198(286,299)(964,300)
TOTAL LIABILITIES AND EQUITY:5,414,176114,3308,747,59116,017,41410,098,081 

Income Statement (P&L) (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues
(Other Income)
 402,394   63 
Gross profit: 402,394   63 
Operating expenses(5,211,809)(2,993,169)(14,486,172)(15,977,943)(954,317)(6,633)
Other undisclosed operating loss (402,394)   (63) 
Operating loss:(5,211,809)(2,993,169)(14,486,172)(15,977,943)(954,317)(6,633)
Nonoperating income (expense)(3,319,211)(5,839,330)(5,404,100)(4,473,137)(2,139,989) 
Investment income, nonoperating (6,672,019) (7,070,841)  
Debt instrument, convertible, beneficial conversion feature   1,357,978   
Interest and debt expense(929,912)(2,960,020)(2,293,858)(4,473,137)(2,140,052) 
Income (loss) from continuing operations before equity method investments, income taxes:(9,460,932)(11,792,519)(22,184,130)(24,924,217)(5,234,358)(6,633)
Other undisclosed income from continuing operations before income taxes 929,912 2,293,8584,473,1372,140,052 
Income (loss) from continuing operations:(8,531,020)(11,792,519)(19,890,272)(20,451,080)(3,094,306)(6,633)
Loss before gain (loss) on sale of properties:(11,792,519)(19,890,272)(20,451,080)(3,094,306)(6,633)
Other undisclosed net income  2,960,020    
Net income (loss):(8,531,020)(8,832,499)(19,890,272)(20,451,080)(3,094,306)(6,633)
Other undisclosed net income attributable to parent      
Net income (loss) available to common stockholders, diluted:(8,531,020)(8,832,499)(19,890,272)(20,451,080)(3,094,306)(6,633)

Comprehensive Income (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(8,531,020)(8,832,499)(19,890,272)(20,451,080)(3,094,306)(6,633)
Comprehensive income (loss):(8,531,020)(8,832,499)(19,890,272)(20,451,080)(3,094,306)(6,633)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent612,335(26,195)(483,409)137,694  
Comprehensive income (loss), net of tax, attributable to parent:(7,918,685)(8,858,694)(20,373,681)(20,313,386)(3,094,306)(6,633)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: